Onk Therapeutics
ONK Therapeutics, is an innovative cell therapy company dedicated to developing a next generation of off-the-shelf, dual-targeted NK cell therapy platform targeting solid and hematological cancers.
Total raised
€26M
€25,721,641
Funding rounds
2
Investors
0
distinct backers
Active since
2020-10
latest 2022-01
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood40
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 11y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-07 | Series A | €19M | — | View deal → |
| 2020-10-19 | Other | €6.8M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech